v3.26.1
Fair Value Measurement - Additional Information (Details)
$ / shares in Units, $ in Millions
 3 Months Ended
Jun. 27, 2025
tranche
$ / shares
shares
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Agreeing to file register statement (in days) 45 days    
Warrants value | $   $ 7.5  
Warrants      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Loss on warrants | $   $ 5.0  
Term Loan 1 | Domestic Line of Credit      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Warrant term 5 years    
Warrants to purchase common stock (in shares) | shares 3,934,776    
Number of tranches | tranche 2    
Right to repurchase percentage (as a percent) 0.50    
Term Loan 1 | Domestic Line of Credit | Debt Instrument, Redemption, Period One      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Right to repurchase percentage (as a percent) 0.50    
Term Loan 1 | Domestic Line of Credit | Vesting period 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Exercise price (in usd per share) $ 1.52    
Term Loan 1 | Domestic Line of Credit | Vesting period 1 | Debt Instrument, Redemption, Period One      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Exercise price (in usd per share) 1.40    
Term Loan 1 | Domestic Line of Credit | Vesting period 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Exercise price (in usd per share) 2.07    
Term Loan 1 | Domestic Line of Credit | Vesting period 2 | Debt Instrument, Redemption, Period One      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Exercise price (in usd per share) $ 1.00    
Interest rate swap agreements      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Proceeds from settlement of derivative contract | $     $ 0.6